Pathologic validation of a model based on diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging for tumor delineation in the prostate peripheral zone

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 3, 2012, Pages

  Groenendaal, Greetje ^a   Borren, Alie ^a   Moman, Maaike R ^a   Monninkhof, Evelyn ^a   Van Diest, Paul J ^a   Philippens, Marielle E P ^a   Van Vulpen, Marco ^a   Van Der Heide, Uulke A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Diffusion weighted imaging; Dynamic contrast enhanced magnetic resonance imaging; Focal boost dose; Gross tumor volume delineation

Indexed keywords

AREA UNDER THE CURVES; CLINICAL TARGET VOLUMES; DIAGNOSTIC PERFORMANCE; DIFFUSION WEIGHTED IMAGING; DOSE PLANNING; DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING; FOCAL BOOST DOSE; GROSS TUMOR VOLUME; LOGISTIC REGRESSIONS; MAGNETIC RESONANCE IMAGES; MODEL OUTPUTS; MODEL VALIDATION; MODEL-BASED OPC; NEGATIVE PREDICTIVE VALUE; POSITIVE PREDICTIVE VALUES; RADIOTHERAPY TREATMENT PLANNING; RECEIVER OPERATING CHARACTERISTIC CURVES; REGISTRATION ERROR; RISK LEVELS; STATISTICAL MODELS; TUMOR DELINEATION;

FOCUSING; PATHOLOGY; RADIOTHERAPY; RESONANCE; TUMORS; UROLOGY;

MAGNETIC RESONANCE IMAGING;

ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; GLEASON SCORE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECEIVER OPERATING CHARACTERISTIC; TREATMENT PLANNING; TUMOR DIAGNOSIS; TUMOR VOLUME; VALIDATION STUDY;

AGED; AREA UNDER CURVE; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MODELS, STATISTICAL; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; ROC CURVE; TUMOR BURDEN;

EID: 84856367234     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.07.021     Document Type: Article

References (29)

1. N. Cellini, A.G. Morganti, and G.C. Mattiucci Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: Implications for conformal therapy planning Int J Radiat Oncol Biol Phys 53 2002 595 599
2. D. Pucar, H. Hricak, and A. Shukla-Dave Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: Magnetic resonance imaging and step-section pathology evidence Int J Radiat Oncol Biol Phys 69 2007 62 69
3. B. Pickett, E. Vigneault, and J. Kurhanewicz Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy Int J Radiat Oncol Biol Phys 43 1999 921 929
4. E.N.J.T. Van Lin, J.J. Futterer, and S.W.T.P.J. Heijmink IMRT boost dose planning on dominant intraprostatic lesions: Gold marker-based three-dimensional fusion of CT with dynamic contrastenhanced and 1H-spectroscopic MRI Int J Radiat Oncol Biol Phys 65 2006 291 303
5. A.K. Singh, P. Guion, and N. Sears-Crouse Simultaneous integrated boost of biopsy proven, MRI defined dominant intra-prostatic lesions to 95 Gray with IMRT: Early results of a phase I NCI study Radiat Oncol 2 2007 36
6. R. Miralbell, M. Moll, and M. Rouzaud Hypofractionated boost to the dominant tumor region with intensity modulated stereotactic radiotherapy for prostate cancer: A sequential dose escalation pilot study Int J Radiat Oncol Biol. Phys 78 2010 50 57
7. ClinicalTrials.gov: FLAME: Investigate the benefit of a focal lesion ablative microboost in prostate cancer. www.ClinicalTrials.gov.
8. P. Gibbs, M.D. Pickles, and L.W. Turnbull Diffusion imaging of the prostate at 3.0 tesla Invest Radiol 41 2006 185 188
9. V. Kumar, N.R. Jagannathan, and R. Kumar Apparent diffusion coefficient of the prostate in men prior to biopsy: Determination of a cut-off value to predict malignancy of the peripheral zone NMR Biomed 20 2007 505 511
10. K. Hosseinzadeh, and S.D. Schwarz Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue J Magn Reson Imaging 20 2004 654 661
11. F.A. Van Dorsten, M. van der Graaf, and M.R.W. Engelbrecht Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer J Magn Reson Imaging 20 2004 279 287
12. J.J. Futterer, S.W.T.P.J. Heijmink, and T.W.J. Scheenen Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging Radiology 241 2006 449 458
13. P. Kozlowski, S.D. Chang, and E.C. Jones Combined diffusion weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis: Correlation with biopsy and histopathology J Magn Reson Imaging 24 2006 108 113
14. G. Groenendaal, C.A.T. van den Berg, and J.G. Korporaal Simultaneous MRI diffusion and perfusion imaging for tumor delineation in prostate cancer patients Radiother Oncol 95 2010 185 190
15. R. Alonzi, A.R. Padhani, and N.J. Taylor Antivascular effects of neoadjuvant androgen deprivation for prostate cancer: An in vivo human study using susceptibility and relaxivity dynamic MRI Int J Radiat Oncol Biol Phys 80 2011 721 727
16. P.S. Tofts, G. Brix, and D.L. Buckley Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: Standardized quantities and symbols J Magn Reson Imaging 10 1999 223 232
17. M.C. Schabel, and D.L. Parker Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences Phys Med Biol 53 2008 2345 2373
18. C. de Bazelaire, N.M. Rofsky, and G. Duhamel Combined t2 and t1 measurements for improved perfusion and permeability studies in high field using dynamic contrast enhancement Eur Radiol 16 2006 2083 2091
19. C. Roberts, R. Little, and Y. Watson The effect of blood inflow and b(1)-field inhomogeneity on measurement of the arterial input function in axial 3d spoiled gradient echo dynamic contrast-enhanced MRI Magn Reson Med 65 2011 108 119
20. H.M. Cheng T1 measurement of flowing blood and arterial input function determination for quantitative 3d t1-weighted DCE-MRI J Magn Reson Imaging 25 2007 1073 1078
21. I. Ocak, M. Bernardo, and G. Metzger Dynamic contrast-enhanced MRI of prostate cancer at 3 T: A study of pharmacokinetic parameters Am J Roentgenol 189 2007 849
22. G. Groenendaal, M.R. Moman, and J.G. Korporaal Validation of functional imaging with pathology for tumor delineation in the prostate Radiother Oncol 94 2010 145 150
23. P.C. Vos, T. Hambrock, and C.A. Hulsbergen-van de Kaa Computerized analysis of prostate lesions in the peripheral zone using dynamic contrast enhanced MRI Med Phys 35 2008 888 899
24. S. Ozer, D.L. Langer, and X. Liu Supervised and unsupervised methods for prostate cancer segmentation with multispectral MRI Med Phys 37 2010 1873 1883
25. X. Liu, D.L. Langer, and M.A. Haider Prostate cancer segmentation with simultaneous estimation of Markov random field parameters and class Trans Med Imaging 28 2009 906 915
26. D.L. Langer, T.H. van der Kwast, and A.J. Evans Prostate cancer detection with multi-parametric MRI: Logistic regression analysis of quantitative t2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI J Magn Reson Imaging 30 2009 327 334
27. Y. Artan, M.A. Haider, and D.L. Langer Prostate cancer localization with multispectral mri using cost-sensitive support vector machines and conditional random fields IEEE Trans Image Process 19 2010 2444 2455
28. B. Turkbey, P.A. Pinto, and H. Mani Prostate cancer: Value of multiparametric MR imaging at 3 t for detection: Histopathologic correlation Radiology 255 2010 89 99
29. A. Oto, A. Kayhan, and Y. Jiang Prostate cancer: Differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging Radiology 257 2010 715 723